FRETS‐VWF73, a first fluorogenic substrate for ADAMTS13 assay
Top Cited Papers
- 21 March 2005
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 129 (1) , 93-100
- https://doi.org/10.1111/j.1365-2141.2005.05420.x
Abstract
A plasma metalloprotease, ADAMTS13, cleaves von Willebrand factor (VWF) multimers and downregulates their activity in platelet aggregation. Functional ADAMTS13 deficiency leads to the accumulation of hyperactive large VWF multimers, inducing a life-threatening disease, thrombotic thrombocytopenic purpura (TTP). Although measuring ADAMTS13 activity is important in TTP diagnosis, existing methods require time and skill. Here, we report a fluorescence resonance energy transfer (FRET) assay for ADAMTS13 activity. We developed a synthetic 73-amino-acid peptide, FRETS-VWF73. Cleavage of this substrate between two modified residues relieves the fluorescence quenching in the intact peptide. Incubation of FRETS-VWF73 with normal human plasma quantitatively increased fluorescence over time, while ADAMTS13-deficient plasma had no effect. Quantitative analysis could be achieved within a 1-h period using a 96-well format in commercial plate readers with common filters. The FRETS-VWF73 assay will be useful for the characterization of thrombotic microangiopathies like TTP and may clarify the importance of ADAMTS13 activity as a predictive marker for various thrombotic diseases.Keywords
This publication has 37 references indexed in Scilit:
- Measurement of von Willebrand factor cleaving protease (ADAMTS‐13): results of an international collaborative study involving 11 methods testing the same set of coded plasmasJournal of Thrombosis and Haemostasis, 2004
- ADAMTS13 and TTP: the clot thickensBlood, 2004
- Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpuraBlood, 2004
- Molecular characterization of ADAMTS13 gene mutations in Japanese patients with Upshaw-Schulman syndromeBlood, 2003
- ADAMTS13 gene mutation in congenital thrombotic thrombocytopenic purpura with previously reported normal VWF cleaving protease activityBlood, 2003
- Mutation analysis and clinical implications of von Willebrand factor–cleaving protease deficiencyKidney International, 2003
- Cloning, expression, and functional characterization of the von Willebrand factor–cleaving protease (ADAMTS13)Blood, 2002
- Assays of von Willebrand Factor- Cleaving Protease: A Test for Diagnosis of Familial and Acquired Thrombotic Thrombocytopenic PurpuraSeminars in Thrombosis and Hemostasis, 2002
- Prevalence of Asymptomatic Carotid Atherosclerotic Lesions Detected by High-Resolution Ultrasonography and Its Relation to Cardiovascular Risk Factors in the General Population of a Japanese CityStroke, 1997
- Unusually Large Plasma Factor VIII: von Willebrand Factor Multimers in Chronic Relapsing Thrombotic Thrombocytopenic PurpuraNew England Journal of Medicine, 1982